Clinical Physiology and Functional Imaging, published by Wiley, is a distinguished journal dedicated to advancing the fields of clinical physiology and biomedical imaging. This UK-based publication, with an ISSN of 1475-0961 and an E-ISSN of 1475-097X, has established itself as an important resource for researchers and professionals from various backgrounds, focusing on the physiological mechanisms underlying human health and disease through innovative imaging techniques. With a convergence year span from 2002 to 2024, the journal is classified within the Q3 quartile across several medical and physiology categories in 2023, reflecting its commitment to quality research amid a competitive landscape. Although it currently lacks an H-index, its rankings within Scopus—#70 in Medicine (Miscellaneous) and #134 in Biochemistry, Genetics and Molecular Biology—underscore its relevance in a rapidly evolving field. Engaging with this journal offers an opportunity to explore emerging research that bridges clinical practice and advanced imaging modalities, making it an essential read for students and established professionals alike.

NEUROMUSCULAR DISORDERS is a premier academic journal published by PERGAMON-ELSEVIER SCIENCE LTD, focusing on the latest research and developments in the fields of neurology, genetics, and pediatric health. With an ISSN of 0960-8966 and an E-ISSN of 1873-2364, this journal has established a significant presence since its inception in 1991, and it continues to contribute to the scientific community with its impactful findings and reviews. The journal boasts a commendable impact factor, reflected in its placement in the Q2 category for Clinical Genetics and Neurology, as well as its positioning in the top tier Q1 for Pediatrics, Perinatology and Child Health according to the latest quartile assessments. With Scopus rankings such as Rank #71/330 in Pediatrics and Rank #51/99 in Clinical Genetics, NEUROMUSCULAR DISORDERS is recognized for its contribution to advancing knowledge in neuromuscular diseases. The journal is essential for researchers, clinicians, and students interested in the intricate relationship between genetics and neurological disorders, providing valuable insights that drive innovation and improve patient care.

Journal of Neuromuscular Diseases, published by IOS PRESS, is a leading platform dedicated to advancing the field of neurology and neuromuscular research. With a focus on delivering high-quality, peer-reviewed content, this journal aims to foster knowledge sharing and collaboration among researchers, clinicians, and healthcare professionals dealing with neuromuscular disorders. The journal boasts a commendable impact factor within its respective categories, achieving Q2 rankings in both Neurology and Clinical Neurology as of 2023. Spanning from its inception in 2014 to the anticipated convergence in 2024, it is recognized for its contributions to critical discussions in the field, evidenced by its rankings of #145 out of 400 in clinical neurology and #75 out of 192 in neuroscience. As an open access journal, it facilitates wider accessibility of research findings, catering to an audience eager for innovative approaches and developments. Set against the backdrop of the vibrant academic scene in the Netherlands, the Journal of Neuromuscular Diseases serves as an essential resource for driving forward the boundaries of knowledge in neuromuscular-related conditions.

Neurology Research International, published by HINDAWI LTD, is an esteemed open access journal that has been serving the neurology community since 2010. With its ISSN 2090-1852 and E-ISSN 2090-1860, this journal aims to foster knowledge dissemination and facilitate dialogue surrounding key issues in neurology and clinical neuroscience, making it a vital resource for researchers, clinicians, and students alike. It operates from the United States, with its administrative hub located in London, England. As of 2023, the journal has been positioned in the Q3 category for both neurology and clinical neurology, reflecting its commitment to advancing research within these critical fields. With a current Scopus rank of #216/400 in clinical neurology and a #113/192 in neuroscience, and a converged publication timeline from 2010 to 2024, Neurology Research International is dedicated to promoting high-quality research that addresses contemporary challenges and innovations in neurological science. By offering open access since its inception, it ensures that cutting-edge research is freely available, aligning with the global push towards accessible scientific communication.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, published by Wiley, is a prestigious peer-reviewed journal dedicated to advancing the understanding of the peripheral nervous system. With an ISSN of 1085-9489 and E-ISSN of 1529-8027, this journal has been a vital resource for researchers and clinicians since its inception in 1996 and continues to publish cutting-edge research through to 2024. Ranked in the second quartile (Q2) in both Medicine (miscellaneous) and Neurology (clinical), and holding a commendable position in the third quartile (Q3) for Neuroscience (miscellaneous), it reflects a strong impact factor within its fields, including a 72nd percentile rank in clinical neurology. The journal focuses on providing a platform for innovative research findings, reviews, and clinical studies that broaden the understanding of peripheral nerve pathophysiology and therapies. Researchers, students, and professionals in neuroscience and related disciplines will find the journal's diverse range of articles invaluable for keeping abreast of the latest developments and fostering scientific dialogue.

The Journal of Electromyography and Kinesiology, published by Elsevier, is a distinguished academic platform that focuses on the intricate interrelations between electromyography, kinetic analysis, and their applications in health and sports sciences. Established in 1991, this journal has maintained a rigorous publication standard and continues to be pivotal in advancing knowledge in biophysics, neurology, and sports science, with impressive Q1 and Q2 ratings in multiple categories as of 2023. With an impact factor that underscores its significance in the scientific community, the journal contributes to a deeper understanding of muscle function and movement patterns, making it an essential resource for researchers, healthcare professionals, and students alike. While it operates under a subscription model, the insights provided by the journal are invaluable for anyone invested in the fields of biomechanics, rehabilitation, and neuromuscular research. For over three decades, this journal has become a cornerstone for disseminating groundbreaking research and fostering collaboration among scholars in the ever-evolving landscape of kinesiology and electromyography.

European Journal of Translational Myology is a premier, open access journal published by PAGEPRESS PUBL, dedicated to advancing research in the dynamic field of myology and its applications in various medical disciplines. Established in 2010, this journal disseminates crucial findings pertinent to translational myology, covering aspects within Cell Biology, Molecular Biology, Neurology, and Orthopedics and Sports Medicine. With a notable presence in the Scopus rankings and respectable quartiles across various categories, including Q3 positions in key areas as of 2023, the journal offers an invaluable platform for researchers and clinicians aiming to bridge the gap between experimental research and clinical practice. Located in Pavia, Italy, the journal welcomes contributions from scholars worldwide, fostering a collaborative environment that enhances knowledge exchange and encourages innovative approaches in myological research.

KLINISCHE NEUROPHYSIOLOGIE is a pivotal journal dedicated to advancing the field of clinical neurophysiology, published by GEORG THIEME VERLAG KG in Germany. With an ISSN of 1434-0275 and an E-ISSN of 1439-4081, this journal aims to disseminate high-quality research findings that enhance our understanding of neurological disorders and their physiological underpinnings. Although currently positioned in the fourth quartile in both Neurology (clinical) and Physiology (medical) categories, the journal offers a unique platform for novel insights and empirical studies, filling a crucial niche within the medical community. Researchers, healthcare professionals, and students can benefit from its Open Access option, which promotes wider accessibility and engagement with cutting-edge scientific discourse. As the journal converges through the years from 1998 to 2024, it remains committed to fostering scholarly collaboration and innovation in neurophysiological research, crucial for improving clinical outcomes.

The Journal of Cachexia Sarcopenia and Muscle is a premier open-access publication dedicated to advancing the understanding of muscle wasting, cachexia, and related disorders. Published by Wiley, this esteemed journal boasts an impressive impact within its fields, achieving a Q1 classification in both Orthopedics and Sports Medicine, and Physiology (Medical) for 2023. With a Scopus ranking of #4 out of 321 in Orthopedics and Sports Medicine, and #10 out of 113 in Physiology, it firmly positions itself at the forefront of medical research. The journal’s scope includes comprehensive studies, reviews, and innovative clinical trials that contribute to the scientific community’s understanding of muscle health and performance. Since its inception in 2010 as an open-access platform, the Journal of Cachexia Sarcopenia and Muscle has facilitated a growing dialogue among researchers, healthcare professionals, and students, emphasizing its crucial role in tackling the multifaceted challenges posed by muscle diseases. For those invested in the latest research trends and clinical advancements, this journal stands out as a vital resource and reference point.

JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY, published by Springer, is a premier journal dedicated to advancing our understanding of muscle biology and cellular motility. With an ISSN of 0142-4319 and an E-ISSN of 1573-2657, this journal stands out in the fields of biochemistry, cell biology, and physiology, proudly holding a Q2 ranking in each of these categories as per 2023 metrics. Covering significant developments from its inception in 1963 to its anticipated contributions through 2024, this journal serves as a vital platform for researchers and professionals to disseminate their findings and insights globally. Although it does not currently offer open access, its robust academic rigor and relevance are evident from its Scopus rankings, making it a crucial resource for those invested in the biological sciences. With a focus on original research articles, reviews, and methodological advancements, the journal fosters innovative collaborations and discussions within the scientific community, making it an invaluable addition to any researcher’s library.